mitoxantrone for cancer
Selected indexed studies
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. (Lancet, 2010) [PMID:20888992]
- Mitoxantrone Combined with Engineered TRAIL-Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. (Adv Healthc Mater, 2024) [PMID:39049538]
- Mitoxantrone-engineered multifunctional nanoplatforms for precision imaging-guided synergistic cancer therapy: recent advances and future perspectives. (J Mater Chem B, 2026) [PMID:41347370]
_Worker-drafted node — pending editorial review._
Connections
mitoxantrone for cancer is a side effect of
Sources
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. (2010) pubmed
- Mitoxantrone. (1986) pubmed
- Mitoxantrone Combined with Engineered TRAIL-Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. (2024) pubmed
- Mitoxantrone-engineered multifunctional nanoplatforms for precision imaging-guided synergistic cancer therapy: recent advances and future perspectives. (2026) pubmed
- Mitoxantrone-Loaded PEGylated Gold Nanocomplexes for Cancer Therapy. (2019) pubmed
- A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer. (2006) pubmed
- Self-assembled IR dye/mitoxantrone loaded Porphysomes nanosystem for enhanced combinatorial chemo-photothermal cancer therapy. (2024) pubmed
- Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review. (1995) pubmed
- γ-Fe(2) O(3) Loading Mitoxantrone and Glucose Oxidase for pH-Responsive Chemo/Chemodynamic/Photothermal Synergistic Cancer Therapy. (2022) pubmed
- Development of Mitoxantrone-Loaded Quercetin Nanoparticles for Breast Cancer Therapy with Potential for Synergism with Bioactive Natural Products. (2024) pubmed